Take a Bow

At the age of eight, Tamar Koren began playing the violin. “I fell in love with the sound of this instrument, a sound full of depth and expression. Over the years, playing the violin became a central part of my life: concerts, courses, master classes, auditions, hours of practice every day. I guess anyone who has been involved in the arts or in sports knows how consuming it is, because every hour of the day counts and there is no such thing as a day without training. Even though it was a lot of pressure, it was a magical world. Through it I met a lot of likeminded musicians, I learned how to keep improving, and how to get up and keep going even when I was told I hadn’t played well enough.”

Tamar graduated from the Thelma Yellin High School with honors in both music and the core subjects, and enlisted in the IDF as an “outstanding musician.” After being discharged, she graduated with a B.Mus. Honors in instrumental performance from the Buchmann-Mehta School of Music at the Tel Aviv University.

And that’s where the plot took a twist: Tamar decided to make a dramatic change in her professional life and apply to medical school. “I was always fascinated by doctors’ ability to treat patients from a place of knowledge, intellect, and understanding of ‘how the body works’. At some point, I decided that even if I did not continue to be a professional violinist, the music would remain with me, and that maybe, thanks to the perseverance and discipline that I’d learned through my practice, I could continue to pursue another dream.” A year later, she began her medical studies at the Ruth and Bruce Rappaport Faculty of Medicine at the Technion.

After three years of pre-clinical studies, Tamar was accepted into the M.D./Ph.D track, a dual doctorate in research and medicine. She carries out her research under Professor Asya Rolls’ supervision, in her lab. “I remember when Asya asked me to start the project that later became my doctoral project, she warned me that it was ‘high-risk high-gain’ – a choice that involved a high-risk gamble. How did that not put me off? The subject, encoding immune information in the brain, sounded both fascinating and abstract, and Asya was infectiously enthusiastic for exploring the subject. I was excited to accept the challenge.”

In their study, carried out on mice, Asya and Tamar tried to find out if the brain could monitor and remember inflammatory events. They found several brain areas that were more reactive during inflammation, and by activating one of them, the insula, were able to reproduce the same inflammatory event from which the mice had already recovered. “We were surprised at how specific the recapitulation of the immune information could be – just by reactivating specific neuronal ensembles in the brain, we could induce inflammation at the exact same site in the body where it initially appeared. Furthermore, we discovered that not only could we produce a recurrent inflammatory event but also alleviate inflammation –if instead of activating the relevant brain region we inhibited it. The study clarified how much of an effect the brain has on gastrointestinal diseases that supposedly have nothing to do with the central nervous system.”

Last November, their findings were published in Cell. “It was very exciting to see the interest the article sparkled in the scientific and medical community. Basically, we made progress towards a better understanding of what are now considered psychosomatic phenomena. Though these phenomena have been known for years, their underlying mechanism remains unclear. Our research provided a physiological basis for the psychosomatic phenomenon through finding immune memories in the brain, a discovery that we hope will lead to new therapeutic avenues and better clinical outcomes in certain diseases.”

“During my years in academia, I discovered that the search for creative solutions, whether in research or medical studies, strengthened my confidence in my ability to deal with different situations and challenges, although it took me a while to figure that out. I remember that at school there was an emphasis on showing proficiency and knowledge, being encouraged mostly to answer questions, and less to ask them. This emphasis brought up feelings of insecurity, because in only answering questions, either you were right or wrong. And if you were wrong, maybe next time you would avoid answering even if you knew the answer, and so the vicious circle continued. Curiosity, however, is neither right nor wrong. And as long as curiosity exists, knowledge will follow. What’s so beautiful about academia and science is that you’re constantly motivated to think, be creative and understand that mistakes are an integral part of the process. Through this I discovered that encouraging questions allows your confidence and your own ideas to flourish, while the fear of being wrong decreases. I believe that this is a way to encourage any young girl, however quiet and insecure, to achieve things she only dreamed of.”

Meet Intl. PhD Student Rongying Huang

Rongying Huang came to the Technion in the summer of 2016 as an international student from China. Today, she is a Ph.D. student in the biotechnology lab, and lives in Haifa with her husband Yang and their two kids – Yuanyi (Yoni) and Miya.  She sat down with us to talk about her journey and why she decided to stay.

 


Why did you decide to come and study at the Technion?

The reason I came to Israel was to take a one-month summer “ulpan” (Hebrew school) as part of my bachelor’s degree. I came in the summer of 2016 to study Hebrew, visited different universities and traveled around, and then decided to come back and study. I was introduced to the universities, research, and innovation companies through the ulpan. For me, the most interesting part was the cutting-edge research.

For me, the most interesting part was the cutting-edge research

 

How did you find the cultural differences between China and Israel?

As you know, China is a very large country, with huge differences between the north and south, east and the west. I lived in Beijing, which is a junction that connects all the points, and my home was very close to the embassy district and the Lama Temple. It’s common to see some religious people in my neighborhood, which gave me a familiar feeling in the religious neighborhoods in Haifa. I also feel different from other Chinese students and identify more with city people – I don’t see such a big difference between Haifa and Beijing. People here like to socialize in the streets – in cafes, listening to live music – the same as in Beijing. Though I think that Chinese people eat more street food.

I don’t see such a big difference between Haifa and Beijing


Tell me about some your challenges here

The biggest challenge I faced at the beginning of my life in Israel was the gap between my academic knowledge and my life skills. If I did it all over again, I would rely more on others for help. Regarding academic studies, I didn’t think deeply enough about the topics or try to solve problems creatively. I had no idea about life here, and practical skills.

I needed to learn how to solve the problem, not only know how to pass the exam

For my bachelor’s degree in Beijing, I only needed to do my homework and submit it. We weren’t encouraged to ask open questions or carry out research. For my master’s degree at the Technion, my professor always encouraged me to learn how to solve the problem and not only know how to pass the exam. At the time, this was a huge challenge for me and very tough. Luckily, I got a lot of help from my professor, lab colleagues, and other students. It’s no longer a challenge.

I am an only child, as is common in China. I grew up in a loving household with my parents and grandparents. I didn’t need to do housework or learn to cook or take care of other siblings. I never needed to share. When I came to study in Israel, it was my first time living alone. I learned to cook from the internet, and in the beginning, it was hard! But this is something that comes with practice and is easily learned. It’s no longer a challenge for me. Sometimes I make shakshuka for my kids.

 

Can you tell me about your Ph.D. research?

Today, I’m a PhD student in the Interdisciplinary Program for Biotechnology. My research, supervised by Professor Daniel Ramez from the Faculty of Biomedical Engineering, is on genetically modifying bacteria to fight cancer. We engineer the bacteria gene into a smart agent and design it to deliver the immunotherapeutic drug to the solid tumor area in a local and controlled way.

Why did you decide to stay in Israel?

After my husband’s master’s degree, he continued with his Ph.D. so we could afford to stay here. Then I also found a Ph.D. position at the Technion, so it made sense to stay in Israel.


What’s it like, bringing up children in Israel?

Israel gave me a chance to bring up kids while studying at the same time.

In Israel, there are many differences in bringing up children compared to China. In Beijing, kids go to the hospital whenever they have fever, a cough, a runny nose, or even loss of appetite. We don’t need to make an appointment or go to the local clinic.

In Israel, there are many daycare options, where kids can go starting when they are 3 months old. This has given me the support to go back to work. In Beijing, kindergartens mostly start from 3 years old. They are bigger institutions, and more like schools. Before the age of 3, most kids stay at home, and are looked after by their grandparents, or one of their parents. This means that I wouldn’t have been able to work had I been in Beijing. Many parents (mostly, moms) need to sacrifice their career to stay with their kids. Israel gave me a chance to bring up kids while studying at the same time.

 

What is special about the Technion, and would you recommend it to others back in China?

After so many years studying in Israel, I don’t have much contact with master’s and Ph.D. students in China. But I have to say, I’ve met and talked to some famous professors who are more like idols or legends in China. Collaboration between China and Israel can really advance progress in science and technology: the Technion has some of the most intelligent people in the world and so many innovative ideas. In China, there is the potential to make these ideas come true. For the Technion, this means expanding the range of research, accelerating startups, and attracting more Chinese students to Israel.

Right now, the combination of my research work and looking after two kids takes up a lot of my time. Before I had kids, I used WeChat and Weibo (the Chinese equivalent of Facebook) to introduce Israel and the Technion to Chinese students. People always ask if it is safe here. I would love to help to introduce more people to the Technion – a peaceful place with cutting-edge research.

A peaceful place with cutting-edge research

 

What advice would you give to another international student who was thinking of coming?

Enjoy the pressure and the challenge. Even though it’s hard, try and embrace the experience.

 

Israel Prize to Profs. Zak, Palti

Two Technion professors will receive the prestigious Israel Prize in May 2022: Prof. Emeritus Joshua Zak of the Faculty of Physics will be awarded the 2022 Israel Prize for Physics and Chemistry Research. Known for the Zak Transform and the Zak Phase, Prof. Zak is awarded for his contribution to the understanding of condensed matter physics. Prof. Emeritus Yoram Palti of the Ruth and Bruce Rappaport Faculty of Medicine will receive the 2022 Israel Prize in the Field of Entrepreneurship and Technological Innovation. Prof. Palti developed groundbreaking cancer treatments that fight malignant brain tumors using electric pulses in a non-invasive manner.

The prizes were recently announced by Israel’s Minister of Educationת Dr. Yifat Shasha-Biton.

Prof. Emeritus Joshua Zak (left), Prof. Emeritus Yoram Palti (right)

His scientific contributions serve, and will continue to serve, in gaining an understanding of the chemistry and physics of material

According to the Israel Prize Committee, Prof. Zak will be awarded the prize for “the development of mathematical tools such as the ‘Zak Transform’ and the ‘Zak Phase’ for the study of quantum phenomena in crystalline solids. These tools allow for the prediction of materials with unique properties to build electronic devices.” The Committee further emphasized that “…his scientific contributions serve, and will continue to serve, in gaining an understanding of the chemistry and physics of material.”

Technion President Professor Uri Sivan commented: “We are honored and exceptionally proud to congratulate Prof. Joshua Zak on being awarded the Israel Prize, and of this important recognition of his contribution to science. Prof. Zak’s research has led to breakthroughs in an understanding of fundamental phenomena that are presented at the forefront of research into quantum mechanics, while contributing greatly to practical engineering applications. Prof. Zak is a member of the generation of giants that founded the Department of Physics at the Technion, laying the foundations for theoretical physics in Israel. This is the second Israel Prize awarded to Technion researchers within a week, and we are literally bursting with pride.”

Joshua Zak, 93, was born in Vilna in 1929. At the age of 12, he and his family were sent to the ghetto, and later, he was deported to forced labor camps and a concentration camp, during which time he lost both parents. As an adolescent, Zak was forced to join the Death March to the west and was released by and immediately recruited to the Red Army – all before he had reached the age of 16. Following his discharge in 1948 he returned to Vilna and began to attend high school, graduating with honors despite having missed many years of schooling due to the war and his military service. When the Korean War broke out, he was again recruited to the Red Army, but was immediately discharged thanks to his brother, Ben-Zion, who persuaded the authorities to permit Joshua to attend university.

He completed his studies in Physics with distinction at Vilnius University in 1955, while simultaneously earning the title of Lithuanian kayak champion. In the same year, he was accepted to further studies in Leningrad and began studying there, but in 1957 was presented with the opportunity to immigrate to Israel, an opportunity he refused to pass up. Within a short time, he was accepted by the Technion, where he completed his doctoral studies under the supervision of Technion Professor Nathan Rosen, who was Albert Einstein’s student and assistant, and Professor Yoel Racah of the Hebrew University of Jerusalem. In 1960, Zak received his D.Sc., spent some time at the Massachusetts Institute of Technology (MIT), and then returned to the Technion, where he began studying in the Department of Physics. Ten years later, he founded, and headed, the Solid State Institute at the Technion.

Professor Emeritus Joseph Avron, staff member at the Technion’s Department of Physics, who studied for his doctorate under Prof. Zak, said, “Prof. Zak’s story is one of the meteoric rise of a boy who was almost completely unschooled, and it was only thanks to his phenomenal talent that in just a couple of years he succeeded in catching up, completing the entire curriculum imparted to children by the educational system over a 12-year period”.

Prof. Zak has many achievements in physics to his credit, two of which are named after him: the Zak Transform, which is presently used in signal processing, and the Zak Phase – a unique 1D crystal phase, which he described in an article in Physical Review Letters in 1989. This prediction has been verified in numerous recent experiments and is widely cited.

As mentioned, this is the second Israel Prize awarded to Technion researchers within a week. Last week, the Committee announced that the 2022 Israel Prize for Entrepreneurship and Technological Innovation had been awarded to Novocure founder Professor Emeritus Yoram Palti of the Rappaport Faculty of Medicine at the Technion. Novocure has developed an innovative technology for the treatment of cancer, which is currently applied in some 250 medical centers worldwide.

Prof. Yoram Palti developed a groundbreaking method for electrical treatment of several types of cancer

Professor Emeritus Yoram Palti of the Technion’s Rappaport Faculty of Medicine is the winner of this year’s Israel Prize in the Field of Entrepreneurship and Technological Innovation.

The Israel Prize committee, explained its decision: “Prof. Yoram Palti developed a groundbreaking method for electrical treatment of several types of cancer. The treatment is non-invasive and highly selective. His personal story is an inspiration, since this type of breakthrough requires thinking outside of the box and a deep conviction, requiring Prof. Palti to challenge and change existing approaches in this field.” The committee added that, “Prof. Palti is working to expand the use of this technology in order to treat additional types of cancer.”

Technion President Professor Uri Sivan said: “We are proud and absolutely delighted by this important recognition and the prestigious prize awarded to Prof. Palti, who not only developed a new technology, but a groundbreaking new approach to the treatment of cancer – an approach that does not involve chemotherapy or other drugs. Prof. Palti’s work is an excellent example of the integration of engineering and medicine – integration that is among the Technion’s most distinctive hallmarks. Prof. Palti is an outstanding model of the rare ability to translate science into applications that are beneficial to people by combining profound research with an entrepreneurial spirit. Congratulations and well done!”

Prof. Palti was born in Haifa in 1937. As a child, he moved to Tiberias, and later to the U.S. When his family returned to Israel, they settled in Jerusalem, where he completed his schooling at the Beit HaKerem High School (now called Hebrew University High School). In 1955, Yoram Palti began studying at the Hebrew University-Hadassah Medical School in Jerusalem. At the army’s request, he took a break from his studies to conduct a research project, and then completed a combined M.D. and Ph.D. degree in Medicine. His thesis focused on a subject that would become his life’s work: the effect of electric fields on live tissue.

He was awarded a post-doctoral fellowship from the National Institutes of Health in the United States, and conducted his post-doctoral research at the University of Maryland in Baltimore. Within one year, he was appointed to the university’s faculty. In 1969, he returned to the Hebrew University, but two years later, was asked to help establish the Technion’s Medical School. Since then, he has linked his fate to that of the Rappaport Faculty of Medicine at the Technion.

Alongside his original research work and management positions at the Faculty of Medicine and at the Rappaport Research Institute, Prof. Palti dedicated himself to translating his innovative research to the clinical field. As a result, he became a serial entrepreneurial – founding a succession of companies, including Carmel Biosensors (monitoring glucose among diabetes patients), EchoSense (diagnosing heart disease), O2Cure (respiratory assistance and artificial lungs), and BetaVive (treatment for diabetes).

The highlight of Prof. Palti’s research and entrepreneurial activities is NovoCure, the company that he founded in 2000, which developed an innovative treatment for cancer patients. The treatment is based on special electric fields (Tumor Treating Fields) that attack the cancerous cells without harming surrounding healthy cells, and therefore do not produce side effects or other risks. Clinical trials began in 2004, and their success led to FDA approval for NovoCure’s technology for the treatment of three types of cancer. Later, the technology received CE approval (the European equivalent of the FDA) for treating all types of solid cancer. Treatments for six additional types of cancer, including pancreatic, liver, ovarian, and lung cancer, are currently at various stages of clinical trials. To date, approximately 20,000 patients have been treated with NovoCure’s technology in around 250 medical centers around the world. The company’s CEO is Asaf Danziger and its Executive Chairperson is Bill Doyle.

Commander’s Medal of the Ordre des Palmes Academiques to Prof. Peretz Lavie

Professor Emeritus Peretz Lavie, President of the Technion from 2009 to 2019, has been bestowed with the Commander’s Medal – the highest award in the French “Ordre des Palmes Academiques” (Palm Order). The Order, founded by Napoleon in 1808, is conferred upon prominent figures from academia and the worlds of culture and education for academic excellence and significant contributions to science, education, and the academic world.

Prof. Peretz Lavie

Prof. Lavie, a world-renowned expert in sleep research, is an entrepreneur and one of the founders of Itamar Medical and other biomedical engineering companies. Prior to his appointment as President of the Technion, he served in other senior positions, including as Dean of the Rappaport Faculty of Medicine and as Vice President of the Technion for Public Relations and Resource Development. In 2015, while serving as President of the Technion, he was appointed Chairman of the Committee of University Heads. Over the years, Prof. Lavie has been a consultant and global expert in the field of sleep, and was involved in several significant public decisions, including the cancellation of “zero hour” classes in elementary schools, the introduction of daylight-saving time, the extension of the minimum sleep time in the IDF, and the “Quiet Wave” radio station during the first Gulf War.

Prof. Lavie currently serves as Chairman of the Israel Friends of the Technion and Chairman of the National Council for Civil Research and Development.

עיטורי מסדר הדקלים של האקדמאים שמעניקה ממשלת צרפת
Ordre des Palmes Academiques medals

Newsletter: Shaping Technion’s Future

We recently released the February edition of our e-newsletter, Technion ‘LIVE,’ which includes a special interview with Technion President Prof. Uri Sivan, a story about a possible cure for ALS, an algorithm that fights antibiotic resistance, scientific experiments in far-away galaxies, and breaking news on two Technion professors who will receive the prestigious Israel Prize in May 2022.

Prof. Emeritus Joshua Zak (pictured, left) of the Faculty of Physics will be awarded the 2022 Israel Prize in the Field of Physics and Chemistry Research. Known for the Zak Transform and the Zak Phase, Prof. Zak is awarded for his contribution to the understanding of condensed matter physics.

Prof. Emeritus Yoram Palti (pictured, right) of the Ruth and Bruce Rappaport Faculty of Medicine will receive the 2022 Israel Prize in the Field of Entrepreneurship and Technological Innovation. Prof. Palti developed groundbreaking cancer treatments that fight malignant brain tumors using electric pulses in a non-invasive manner.

To read the latest edition of ‘Technion LIVE,’ click here. To get our e-newsletter straight to your inbox, click here.

 

Two Technion researchers won prestigious Proof of Concept grants from the European Commission for Research (ERC)

Two Technion faculty members have won Proof of Concept (PoC) grants from the European Commission for Research (ERC). The prestigious grants, each worth €150,000, are intended to promote the application and commercialization of academic research, including the establishment of a start-up company. They are awarded only to researchers who have won an ERC grant in the past. In the current round, 348 applications were submitted of which 166 research proposals were selected. Eighteen of the winning proposals were from Israelis, two of whom are faculty members at the Technion: Professor Shulamit Levenberg from the Faculty of Biomedical Engineering, and Professor Shahar Kvatinsky from the Andrew and Erna Viterbi Faculty of Electrical and Computer Engineering.

פרופ' שולמית לבנברג

Prof. Shulamit Levenberg from the Faculty of Biomedical Engineering won an award for her innovative development for 3D bioprinting and post-printing tissue growth: Print and Grow

Three-dimensional (3D) bioprinting is one of the most promising technologies in the world for tissue engineering, and its corresponding leading technology is bioprinting using suspended hydrogels. In this method, hydrogel living cells are incorporated within bioinks extruded layer by layer onto a granular support material which undergo gelation through diverse cross-linking mechanisms. This technology provides precise fabrication of complex structures but turning the resulting structure into quasi-natural tissue requires additional steps after printing, including cell growth in those structures. At these stages a significant problem arises: the printed structures undergo various structural changes, including contraction and deformation, and the result is a gap between the desired engineered tissue and that actually obtained.

The solution developed at the Levenberg Laboratory is the Print and Grow concept. “With this technology,” explained Prof. Levenberg, “we achieve long-term structural stability of the printed structures, through a unique microwave, improved structural support and continuous real-time monitoring of tissue growth. The first experiments we did with the method led to a high life of the engineered tissue, while maintaining its desired structural properties (shape and size). We intend to improve the properties of the support materials and develop techniques suitable for different sizes, different tissue types, and production on a large scale. And the efficiency of bio-printing for tissue engineering, discovery of new drugs, and the civilized meat industry.”

פרופ' שחר קוטינסקי

Prof. Shahar Kvatinsky from the Andrew and Erna Viterbi Faculty of Electrical and Computer Engineering, received a grant for the development of Real Processing in Phase Change Memory (PCM). One of the bottlenecks in computer performance today is the communication between the two “brains” of the traditional computer – the processor and the memory. Although the capabilities of processors are improving at a rapid pace, the “dialogue” between the processor and memory requires a relatively long time that prolongs the performance of tasks on the computer. Based on the previous ERC grant he received (Starting Grants category), Prof. Kvatinsky developed an innovative unit called mMPU that combines processing and storage in the same cell. As part of the new grant, he intends to connect this to the “Phase Change Memory” (PCM) technology, which is based on monitoring changes in the electrical resistance of the material. This technology is already commercially available, and according to Prof. Kvatinsky, “A successful demonstration of a mMPU unit based on phase change memory may lead to the design and construction of fast and energy efficient computers, that are cheaper than existing computers. Such a breakthrough will dramatically affect different applications such as artificial intelligence, databases, and genomics.”

For the announcements of the ERC grants:

https://erc.europa.eu/news/erc-2021-proof-of-concept-grants-results